Cases & Deals

Seattle Genetics builds patent portfolio for antibodies and antibody-drug conjugates for cancer treatment

Clients Seattle Genetics, Inc.

Jones Day assisted with the portfolio development for Seattle Genetics, Inc. regarding its patent portfolio relating to antibodies and antibody-drug conjugates for treatment of cancer.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.